127 related articles for article (PubMed ID: 4353914)
1. [Structure-activity relationships in acetylcholinesterase reactivators inhibited by organophosphorus compounds. IV. N-hydroxyimidazole-3-oxides and their quaternary salts].
Franchetti P; Grifantini M; Lucarelli C; Stein ML
Farmaco Sci; 1972 Jan; 27(1):46-59. PubMed ID: 4353914
[No Abstract] [Full Text] [Related]
2. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. V. Quaternary salts of hydroxyiminomethylimidazoles.
Grifantini M; Martelli S; Stein ML
J Pharm Sci; 1972 Apr; 61(4):631-3. PubMed ID: 5062578
[No Abstract] [Full Text] [Related]
3. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 6. 2-Hydroxyiminomethylimidazolium iodides.
Grifantini M; Martelli S; Stein ML
J Med Chem; 1973 Aug; 16(8):937-9. PubMed ID: 4745838
[No Abstract] [Full Text] [Related]
4. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 7. 1-Aryl-2-hydroxyiminomethyl-3-methylimidazolium iodides.
Franchetti P; Grifantini M; Martelli S
J Med Chem; 1974 Jan; 17(1):18-22. PubMed ID: 4808466
[No Abstract] [Full Text] [Related]
5. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.
Gray AP
Drug Metab Rev; 1984; 15(3):557-89. PubMed ID: 6386410
[No Abstract] [Full Text] [Related]
6. Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes: synthesis and biological activity.
Chennamaneni SR; Vobalaboina V; Garlapati A
Bioorg Med Chem Lett; 2005 Jun; 15(12):3076-80. PubMed ID: 15908205
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 10. Hydroxyiminomethylarylethenylpyridine methiodides.
Arena F; Manna F; Pizza C; Stein ML; Grifantini M
J Med Chem; 1975 Nov; 18(11):1147-50. PubMed ID: 1177261
[TBL] [Abstract][Full Text] [Related]
8. [Structure-activity relationships in reactivators of acetylcholinesterase inhibited by organophosphoric compounds. 8. Halides of 2- and 4-hydroxy-iminomethyl-1-(omega-(4-imidazolyl)-n-alkyl)pyridinium].
Franchetti P; Grifantini M; Martelli S; Stein ML
Farmaco Sci; 1974 Apr; 29(4):309-16. PubMed ID: 4857121
[No Abstract] [Full Text] [Related]
9. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. XI - Bisquaternary compounds of beta-(4-pyridyl)acraldoxime.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S
Farmaco Sci; 1977 Dec; 32(12):905-8. PubMed ID: 563345
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Part 2.
Mager PP; Das Gupta S
Pharmazie; 1982 Aug; 37(8):607-8. PubMed ID: 7146070
[No Abstract] [Full Text] [Related]
11. New oxime reactivators connected with CH2O(CH2)nOCH2 linker and their reactivation potency for organophosphorus agents-inhibited acetylcholinesterase.
Yang GY; Oh KA; Park NJ; Jung YS
Bioorg Med Chem; 2007 Dec; 15(24):7704-10. PubMed ID: 17869525
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase.
Acharya J; Gupta AK; Dubey DK; Raza SK
Eur J Med Chem; 2009 Mar; 44(3):1335-40. PubMed ID: 18396353
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 9. N-Heterocyclic acraldoximes methiodides.
Franchetti P; Grifantini M; Martelli S
J Med Chem; 1975 Aug; 18(8):839-42. PubMed ID: 1159702
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for reactivators of organophosphorus-inhibited acetylcholinesterase: quaternary salts of 2-[(hydroxyimino)methyl]imidazole.
Bedford CD; Harris RN; Howd RA; Miller A; Nolen HW; Kenley RA
J Med Chem; 1984 Nov; 27(11):1431-8. PubMed ID: 6492073
[TBL] [Abstract][Full Text] [Related]
15. Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 4. Effect of various side-chain substituents on therapeutic activity against anticholinesterase intoxication.
Goff DA; Koolpe GA; Kelson AB; Vu HM; Taylor DL; Bedford CD; Musallam HA; Koplovitz I; Harris RN
J Med Chem; 1991 Apr; 34(4):1363-8. PubMed ID: 2016711
[TBL] [Abstract][Full Text] [Related]
16. [Potential acetylcholinesterase reactivators. 7. Esters of pyridine-N-oxide carbaldehyde oximes and their quaternary derivatives].
Schnekenburger J; Heber D
Arch Pharm (Weinheim); 1975 Jan; 308(1):33-41. PubMed ID: 1119906
[No Abstract] [Full Text] [Related]
17. [Reactivation of phosphorylated acetylcholinesterase (AChE): quaternary salts of vinylogous pyridinaldoxims (author's transl)].
Hagedorn I; Hohler W
Arzneimittelforschung; 1976; 26(8):1515-7. PubMed ID: 1036947
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three enzymatic models for evaluation of reactivators of organophosphorus ester inhibited acetylcholinesterase.
Miller A; Nolen HW; Jackson SE; Howd RA; Harris RN; Bedford CD
Proc West Pharmacol Soc; 1984; 27():297-301. PubMed ID: 6494168
[No Abstract] [Full Text] [Related]
19. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin.
Kuca K; Cabal J; Jun D; Hrabinova M
Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
